Aldeyra Therapeutics, Inc. (ALDX)
1.705
-0.08
(-4.21%)
USD |
NASDAQ |
May 27, 15:56
Aldeyra Therapeutics Free Cash Flow : -25.99M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Alnylam Pharmaceuticals, Inc. | 641.34M |
| AbbVie, Inc. | 19.98B |
| Rhythm Pharmaceuticals, Inc. | -160.46M |
| Catalyst Pharmaceuticals, Inc. | 208.13M |
| ADMA Biologics, Inc. | 107.55M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.110M |
| Cash from Financing (Quarterly) | 0.0711M |
| Free Cash Flow Per Share (Quarterly) | -0.0847 |
| Free Cash Flow to Equity (Quarterly) | -5.093M |
| Free Cash Flow to Firm (Quarterly) | -4.641M |
| Free Cash Flow Yield | -25.33% |